Clinical dynamics of Dienogest for the treatment of endometriosis: from bench to bedside

Abstract

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (14)

• A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis via openalex
• Analysis of psychopathological comorbidity behind the common symptoms and signs of endometriosis via openalex
• CD4+Foxp3+ regulatory T cell differentiation mediated by endometrial stromal cell-derived TECK promotes the growth and invasion of endometriotic lesions via openalex
• Development of a mouse model for testing therapeutic agents: the anticancer effect of dienogest on endometrial neoplasms via openalex
• Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis via openalex
• Effect of dienogest administration on angiogenesis and hemodynamics in a rat endometrial autograft model via openalex
• Efficacy and safety of dienogest in patients with endometriosis: A single-center observational study over 12 months via openalex
• New trends of progestins treatment of endometriosis via openalex
• Pharmacokinetic study of single and multiple oral administrations of 2 mg dienogest in healthy Korean women via openalex
• Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment via openalex
• W2164385268 via openalex
• W2163315477 via openalex
• W2021687464 via openalex
• W2079421112 via openalex

Cited by (50)

• The effect of dienogest treatment on anti-Mullerian hormone in patients with endometrioma: a 12-month follow-up study 2024
• Hormonal Therapies before In-Vitro Fertilization in Women with Endometriosis 2024
• In Vitro Anti Angiogenetic Activity of Traditional Plants Saraca asoca, Glycyrrhizia glabra and Curcuma longa Beneficial for Endometriosis Treatment 2024
• Hormonal Therapies before in vitro fertilization in women with endometriosis: The Minotaur's Labyrinth and the Ariadne's Thread 2024
• Minimally-invasive multidisciplinary treatment of deep endometriosis: 103 cases 2024
• Dienogest alone or dienogest combined with estrogens in the treatment of ovarian endometriomas, that is the question. A retrospective cohort study. 2023
• THE LATEST VIEWS ON THE TREATMENT OF ENDOMETRIOS 2023
• The Role of Quercetin for the Treatment of Endometriosis and Endometrial Cancer: A Comprehensive Review 2023
• Comparison of the efficacy of dienogest and GnRH-a after endometriosis surgery 2023
• Effects of sensate focus technique and position changing on sexual function of women with deep-infiltrating endometriosis after surgery: A clinical trial study 2023
• Dienogest alone or dienogest combined with estrogens in the treatment of ovarian endometriomas, that is the question. A retrospective cohort study 2023
• The relationship between pain intensity and insomnia in women with deep endometriosis, a cross-sectional study 2022
• Treatment of endometriosis with dienogest in combination with traditional Chinese medicine: A systematic review and meta-analysis 2022
• Dietary supplements for treatment of endometriosis: A review. 2022
• Psychological Considerations in Endometriosis 2022
• Complementary pain management in endometriosis: a narrative review 2022
• Are double-J stents in surgery for deep infiltrating endometriosis always necessary? A retrospective analysis 2022
• Deep Infiltrating Endometriosis Malignant Invasion of Cervical Wall and Rectal Wall With Lynch Syndrome： A Rare Case Report and Review of Literature 2022
• Metformin as a Potential Treatment Option for Endometriosis 2022
• Advances in targeting estrogen synthesis and receptors in patients with endometriosis 2022
• Can Laparoscopic Cystectomy Improve Pregnancy Outcomes in Endometrioma? A Prospective Clinical Trial Study. 2022
• Comparison of Efficacy and Safety between Dienogest and Danazol in Women with Endometriosis 2022
• Additional file 1 of Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients 2021
• Effects of the SARS-CoV-2 pandemic on women affected by endometriosis: a large cross-sectional online survey 2021
• Additional file 1 of Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients 2021
• Study of dienogest clinical efficacy in the treatment of adenomyosis 2021
• EXPERIENCE OF LONG-TERM USE OF DIENOGEST FOR THE TREATMENT OF ADENOMYOSIS 2021
• Additional file 1 of Anastrozole and levonorgrestrel-releasing intrauterine device in the treatment of endometriosis: a randomized clinical trial 2021
• Systematic review and Meta-analysis of efficacy and safety of dienogest in treatment of endometriosis 2021
• PPARγ Agonists: Emergent Therapy in Endometriosis 2021
• Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients 2021
• Quality of life in women with endometriosis: a narrative overview 2020
• Novel triple therapy for hemorrhagic ascites caused by endometriosis: A case report 2020
• DIENOGEST IN POST OPERATIVE MANAGEMENT’S OF PATIENT’S WITH ENDOMETRIOSIS 2020
• Dienogest suppresses cellular proliferation status of endometrial polyps and acts differently depending on the morphological type 2020
• Novel triple therapy for hemorrhagic ascites caused by endometriosis: A case report 2020
• Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial. 2020
• Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial. 2020
• Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial. 2020
• Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial. 2020
• The Burden of Endometriosis on Women’s Lifespan: A Narrative Overview on Quality of Life and Psychosocial Wellbeing 2020
• Postoperative management of patients with endometriosis 2020
• Curcumin and Endometriosis 2020
• Dienogest and the Risk of Endometriosis Recurrence Following Surgery: A Systematic Review and Meta-analysis 2020
• Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study 2020
• Sexuality in women with endometriosis: a critical narrative review 2020
• Letter to the Editor in Response to “Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally” 2019
• Management of women affected by endometriosis: Are we stepping forward? 2019
• Bioinformatics approach reveals the key role of C‑X‑C motif chemokine receptor 2 in endometriosis development 2018
• Efficacy of levonorgestrel releasing intrauterine system as a postoperative maintenance therapy of endometriosis: A meta-analysis 2018

Source provenance

europepmc

last seen: 2026-06-18T06:15:08.409253+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-05-13T22:20:25.745717+00:00